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Abstract. The number of identifiable stages and ex-
pression of differentiation markers in cells of the os-
teoblast lineage are not well understood. In the pres-
ent study, a mAb, designated rat bone marrow (RBM)
211.13, was prepared that stained selectively the osteo-
genic and preosteoblastic cells along the surfaces of
bone in calvariae, femurs, and metatarsals. The stain-
ing was cell surface associated and coincided with that
for alkaline phosphatase (APase) detected histochemi-
cally. Only cells positive for APase activity by bio-
chemical assay and not those without APase activity
(e.g., fetal rat skin) stained with RBM 211.13. By im-
munoblotting, RBM 211.13 recognized a band coincid-
ing with APase activity on nonreducing/nondenaturing
gels, and RBM 211.13 precipitated a protein which on
reduced gels migrated with an apparent molecular
mass of rv80 kD. RBM 211.13 labeling was abolished
by phosphatidylinosital-specific phospholipase C,
known to release APase from the cell surface. All of
these data support the concept that RBM 211.13 recog-
nizes the bone isoenzyme of APase. RBM 211.13 was
used to sort by flow cytometry the APase-positive and
APase-negative cells from mixed fetal rat calvaria
(RC) cell populations. The osteoprogenitors we
identified earlier that form bone nodules in vitro (Bel-
lows, C. G., J. E. Aubin, J. N. M. Heersche, and
BONE is ahighly organizedtissue comprising a calcified
connective tissue matrix and specific bone cells (os-
teoblasts, osteocytes, osteoclasts, and their precur-
sors) (Rodan and Rodan, 1984; Nijweide et al., 1986;
Caplan, 1988; Marks andPopoff, 1988; Owen, 1988; Aubin
et al., 1990; Heersche and Aubin, 1990). While the impor-
tance ofthe regulation ofproliferation and differentiation of
theprogenitor cells forosteoblasts is recognized, itis poorly
understood. The currentconceptis that the osteoprogenitors
are undifferentiated mesenchymal cells residing in the
stromal tissues surrounding bone marrow and in other con-
nective tissue compartments, e.g., the periosteal layer of
bone itself (Owen, 1985). However, the number of steps
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1990. Dev. Biol. 140:132-138) were found within the
APase-positive pool. By immunopanning, RC cells
were separated into APase-enriched (APase-positive,
adherent) and APase-depleted (APase-negative, nonad-
herent) populations. The APase-positive fraction was
enriched two-to-threefold for bone-forming osteopro-
genitors compared to unfractionated cells, while the
APase-negative population formed very few nodules
under the same conditions. Both populations
responded to the glucocorticoid dexamethasone (DEX)
with an increase in bone nodule formation. However,
the fold stimulation in bone formation in the APase-
negative population was -30-fold, while the fold stim-
ulation in the APase-positive population was only rv5-
fold. These data suggest that APase expression can be
used for immunoselection to fractionate osteoblastic
populations into an APase-positive population and a
population initially APase-negative, that virtually all
osteoprogenitors forming bone in vitro in the absence
of added glucocorticoids reside in the APase-positive
pool, and that the only osteoprogenitors present in the
APase-negative pool are those requiring DEX to
differentiate.
leading from uncommitted to committed osteoprogenitor
through to terminally differentiated osteocyteis not known,
partly due to the absence of well-defined markers for each
stage of the progression through the lineage. The need for
unambiguous delineation of steps in the osteogenic pathway
becomes increasingly crucial as attempts are made to define
commitment and restriction points in multipotential cells
(e.g., Grigoriadis et al., 1988) and to define target popula-
tions for regulation by oncogenes (e.g., c-fos; Ruther etal.,
1987) or growth factors (e.g., TGFO; Joyce et al., 1990).
Recently, we have developed and used a colony assay to
study the regulation of osteoprogenitor cells present with-
in fetal rat calvaria (RC)1 cell populations in vitro (Bellows
1. Abbreviations used in this paper: DEX, dexamethasone, RBM, rat bone
marrow; RC, rat calvaria.
373et al ., 1986). However, studies to assess the direct versus the
indirect effects ofvarious growth factors on the osteoprogeni-
tors have been hampered by the fact that these cells are pres-
ent at a very low frequency (<1 %) in the primary RC popula-
tions (Bellows and Aubin, 1989), andateven lowerfrequency
in first subculture populations (Bellows et al., 1987, 1990).
While cell cloning procedureshave beenuseful to isolate nor-
mal osteoblastic cells (Aubin et al., 1982; Guenther et al.,
1989), the stages of differentiation represented by such clo-
nal populations are uncertain and none has yet appeared to
represent the bone-forming osteoprogenitors, consistent
with their low frequency in the mass populations. Therefore,
other approaches are required for isolation of these cells.
Specific morphological and histochemical changes help to
describe stages during osteoblast differentiation in vivo
(Caplan, 1988). Acquisition of biochemical properties, e.g.,
alkaline phosphatase activity, and expression of certain bone
matrix-associated proteins, such as osteocalcin and osteo-
pontin, are useful (Buder,1989), butcannot yet be associated
unambiguously with cellsat precise stages of differentiation
or to a subspecialization ofalready matured or differentiated
osteoblasts. The need exists for identification of other mole-
cules or novel use of molecules already knownto aid in dis-
crimination of different stages of differentiation from early
progenitors to mature osteoblasts and osteocytes.
Here we report the production and characterization of a
mAb recognizing osteoblasts and osteoprogenitors in rat
bone tissue. A variety of assays suggests that this antibody
recognizes an epitope on the bone isoenzyme of alkaline
phosphatase (APase) . We have used the antibody to identify
cells in vivo and in vitro and to isolate by cell sorting and
panning the APase-positive and -negative cells from freshly
isolated mixed populations of RC cells. We found that the
bone-forming osteoprogenitor cellscan be enriched for in the
APase-positive fraction, but that a second class of osteopro-
genitor cell, those requiring glucocorticoids to make bone
in vitro, are present in the APase-negative fraction of cells.
Materials andMethods
CellsandCellCulture
Populations of fetal RC cells were prepared by enzymatic digestion of cal-
variaefrom21-d-oldfetusesoftimed-pregnantWistar rats as described (Rao
et al., 1976; Bellows et al., 1986; Turksen et al., 1990). Briefly, calvariae
were dissected aseptically, the loosely adherent soft connectivetissues were
removed, andthecalvariaeweremincedandtreated with a collagenase mix-
ture. Five populations (RCI through RCV) were obtained after sequential
digestion times of -10, 20, 30, 50, and 70 min, respectively, by collecting
released cells through a sterile filter (200 mesh, pore size 74 Am) . Popula-
tion I (RCI) was discarded; populations II through V (RCII-Rcv) were
maintained separately or pooled and plated into T-75 tissue culture flasks
in ciMEM containing 15% heat-inactivated (30 min 56°C) FCS (CellectR
Silver FBS; Flow Laboratories, Inc., McLean, VA) and antibiotics (100
Wg/ml penicillin G (Sigma Chemical Co., St. Louis, MO); 50 pg/ml gen-
tamycin (Sigma Chemical Co.); 300 ng/ml fungizone (Flow Laboratories,
Inc.). Cells were grown at 37°C ina humidified atmosphere of95 % air/5 %
CO2. After 24 h incubation, attached cells were washed with PBS to re-
move nonviable cells and other debris andthen released with0.01% trypsin
incitrate saline. Aliquots werecounted with aCoulter Counter and replated
at thedensities and for the time periods indicated in individual experiments;
usually 3-5 d of recovery and growth were allowed before cytometric or
panning experiments were begun.
The rat osteoblastic osteosarcoma cell lines, UMR 106.06 (kindly pro-
vided by Dr. T. J. Martin, St. Vincent's Instituteof Medical Research, Mel-
bourne, Australia) and ROS 1712.8 (kindly provided by Dr. G. A. Rodan,
Merck Sharp and Dohme Research Laboratories, West Point, PA), were
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grown in high glucose containing DME (HG-DME) and aMEM, respec-
tively; both media were supplemented with FBS and antibiotics as above.
Cells were used in particular experiments as described below.
Bone Nodule Formation
The assay for bone nodule formation was asdescribed (Bellows etal., 1986;
Turksen et al., 1990). Panned (adherent or nonadherent cells), sorted, or
unsorted fetal RC cells were counted and control and treated ineach experi-
ment were adjusted to the same cell density, a density chosen to yield ade-
quate bone noduleformation for counting and statistics. Therecovered cells
wereplated into 35-mm tissue culture dishes (Falcon 3001; Becton Dickin-
son & Co., Mountain View, CA) at a density of3 x 10°-105 cells per dish
in aMEM containing 15 % heat-inactivated FBS and antibiotics (as above)
(standard growth medium) supplemented with 50 pg/ml ascorbic acid
(Fisher Scientific Comp., Fair Lawn, NJ) (AA) and 10 mM sodium-S-
glycerophosphate (,8-GP) BDH Chemicals, Poole, England) (supplemented
growth medium) (day 0). The next day (day 1), the medium was changed
to supplemented medium with or without 10
-s M dexamethasone (DEX).
DEX stocks were prepared at a concentration of 1 mM in absolute ethanol;
the ethanol concentration in the culture medium never exceeded 0.1%. The
medium was changed completely every 2 d and cultures were maintained
for 17-19d. Cultureswere terminated by fixing them in neutral buffered for-
malin, stained by the vonKossatechnique for calcium mineraldeposits, and
bone nodules were counted on adissecting microscope as described by Bel-
lows et al. (1986).
The Production ofAntibodies
Bone marrow stromal cells were prepared from adult male Wistar rats as
described (Maniatopoulos et al., 1988) . First subculture cells were plated
at 103 cells/cm' in 150-cm2 round tissue culture dishes and grown as above
until bone nodules were formed and had started to mineralize. The cells
were washed 3 x with PBS, recovered by gentle scraping, and pipeted
repeatedly to form a largely single cell suspension. Young female Balb/c
mice were immunized with three consecutive intraperitoneal injections of
the stromal cells (107 cells/0.2 ml/mouse) at 3-wk intervals. 3 d after the
final injection, spleen cells from immune micewere fused withthe myeloma
cell line SP2/0 (Shulman et al., 1978) (kindly providedby Dr. M. Shulman,
Department of Immunology, University of Toronto), with 50% polyethyl-
ene glycol (PEG) (PEG 1000, Sigma Chemical Co.) as fusion agent. After
fusion, cells were distributed in microtiter plates (Nunc, Roskilde, Den-
mark) and hybridomas were selected by growth in HAT medium as de-
scribed (Kohler and Milstein, 1975; Galfre et al., 1977; Connor et al.,
1983). Supernatants from wells with growing cells were assayed after 15-
20 d by indirect immunofluorescence on RC frozen sections (see below).
Selected hybridomas were cloned by limiting dilution. One such hybridoma
was rat bone marrow (RBM) 211 and the subclone RBM 211.13 was used
in all experiments reported here.
The isotype of RBM 211.13 was determined by inununoprecipitation
using immunodiffusion plates (The Binding Site Ltd, University of Bir-
mingham Research Institute, Birmingham, UK).
Preparation ofAscites Fluid
To obtain ascites fluid, 106 cloned hybridoma cells were injected in-
traperitoneally into Balb/c mice that had been primed with 0.5 ml Pristane
(2, 6, 10, 14-tetramethylpentadecane) (Aldrich Chemical Co., Milwaukee,
WI) 10-15 dearlier. Ascites fluids were collected, centrifuged, and the IgG
fraction from the ascites fluid was purifiedby chromatography on columns
of protein A-Sepharose (Pharmacia Fine Chemicals Co., Montreal, PQ).
ScreeningAssayforSelection ofRBM211.13
Supernatants fromwellswith goodhybridomagrowth were screened on fro-
zen sections prepared from calvariae from 21 d fetalWistarrats. The calvar-
iae were removed from the fetuses in such a fashion as to leave periosteum,
soft connective tissue, and skin intact. Calvariae were immersed in liquid
nitrogen immediately and stored at -80°C until needed. To prepare frozen
sections, thetissues were mounted on aluminum chucks in TissueTekOCT
(LabTek Division, Miles Laboratories Inc. Naperville, IL) and 6-8 Am
sections were cut on a cryostat at -20°C. The sections were collected on
8- or 12-well slides (Carlson Scientific Inc., Peotone, IL) and used either
immediately or stored at -80°C until needed. Antibodies were selected for
bone-specific or bone-associated staining according to the immunofiuores-
cence procedure outlined below.
374Immunofuorescence
On Frozen Sections. Cryostat sections were air-dried for 30 min at room
temperature, fixed in 1-3.7% (vol/vol) formaldehyde (Fisher Scientific
Comp.) in PBS for 5 min at room temperature and postfixed in -20°C
methanol for 5 min. The sections were rinsed in PBS 3x and then incubated
with 3% (wt/vol) BSA (essentially fatty acid free; Sigma Chemical Co.) pre-
pared by heating at 80°C for 3 min in PBS. The sections were incubated
with the BSA solution for 1 h at 37°C to block nonspecific sites. Sections
were then overlayed with antibodies; culture supernatants were used un-
diluted, unpurified ascites fluids werediluted 1:800 in PBS, affinity-purified
ascites fluid was diluted 1:100 in PBS. After incubation for 30 min at room
temperature, the sections were rinsed with PBS and incubated with FITC-
conjugated, affinity-purified F(ab)2 fragments of sheep anti-mouse IgG
(NEN, Boston, MA) (1:75 dilution in PBS) for 30min at room temperature.
Sections were rinsed with PBS, mounted with Moviol (Hoechst Ltd, Mon-
treal, PQ, and observed with a Zeiss Photomicroscope III (Zeiss, Ober-
kochen, WestGermany) equipped with epifluorescence filters. Photographs
were taken using Kodak (Eastman Kodak Co., Rochester, NY) T-Max 400
ASA or P3200 ASA films and developed with Kodak TMax developer.
On Cultured Cells. Immunofluorescence on cultured cells was done es-
sentially as described (Turksen et al., 1988). Washing, incubations with an-
tibodies, mounting, and photography were as above.
Control samples were stained with an unrelated hybridoma supernatant
or supernatant of the SP2/0 myeloma cells or FTPC-(Fab)2-SAM alone.
Electrophoresis
PAGE was performed using the buffer system describedby Laemmli (1970).
Gels were run on amini-gel apparatus at 150 V constant voltage. The com-
mercially available molecular weight markers (BRL, Gaithersburg, MD)
were used.
Immunoprecipitation
The immunoprecipitation procedure has been described in detail (Kubota
et al., 1989). UMR 106.06 or RC U-V cells were used for these experiments.
The specific immunoprecipitate was dissolved, boiled in Laemmli sample
buffer, and the proteins were analyzed under reducing conditions by SDS-
PAGE on a 10% gel and prepared for fluorography (Bonner and Laskey,
1974). The dried gel was exposed toKodak SD-5 X-ray filmat 70°C. Mo-
lecular weights were estimated using [t°C]methylated protein standards
(Gibco BRL, Burlington, Ontario).
Immunoblotting
The methodof Towbin et al. (1979) was used to transferproteins from SDS-
PAGE gels to nitrocellulose sheets. At the completion oftransfer, the sheets
were blocked by 3% (wt/vol) BSA in PBS at 37°C for 2 h and incubated
with ascites fluid of RBM 211.13 (1:1,000 dilution) overnight at room tem-
perature on a shaker. The sheets were then washed 3x for 10min each with
PBS containing 0.05% Tween 20 and incubated with affinity-purified,
peroxidase-conjugated rabbit anti-mouse IgG (Bio Rad Canada, Missis-
sauga, Ontario) diluted 1:1,000. The reaction was developed with 4-chloro-
1-naphthol. Control samples were treated with an unrelated hybridoma
supernatant or supernatant of the SP2/0 myeloma cells or labeled second
antibody alone.
Alkaline PhosphataseActivity
To localize APase histochemically, cells were fixed and incubated for 15
min at room temperature with 15 mg naphthol ASTR phosphate (Sigma
Chemical Co.) dissolved in 0.25 ml N,N-dimethylformamide (Fisher
Scientific Comp.) and 50 ml 0.1 M Tris buffer, pH 8.9, with 30 mg Fast Red
Violet LB salt (Sigma Chemical Co.). To detect APase activity in SDS-
PAGE, the method ofTrepanier et al. (1976) was used. APase activity was
measured quantitatively in samples of cell homogenates as described by
1lrrksen et al. (1990).
Reatment withPI-PLC
UMR 106.06 cells grown on coverslips were rinsed 3 x with serum-free
aMEM, incubated with 20 ng/ml PI-PLC (ICN) for 60 min at 37°C and
then prepared for immunofluorescence as described above. Intensity of
labeling with RBM 211.13 antibodies was compared in PI-PLC treated and
untreated cells.
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Reatment withPNGaseF
UMR 106.06cell homogenateswereelectrophoretically transferredasabove.
After the transfer, the nitrocellular strips were incubated with PNGase F
(0.6 U/ml) (Boehringer Mannheim Biochimica, Montreal, PQ for 24 h at
37°C as described by Tarentino et al. (1985). After enzyme treatment, the
strips were processed for immunoblotting as above.
Flow Cytometry
RC cells were prepared as above and plated. After 1 d, individual popula-
tions were trypsinized (0.01% trypsin in citrate saline) and counted. For the
quantitation of REM 211.13 positive cells, we plated 2.5 x 10, cells per
T75 flask from each population. Where indicated, RC H-V mixed popula-
tions were prepared by mixing equal volumes of cells from each separate
population. These cultures were maintained for 3-5 d in culture in sup-
plemented medium as above and labeled with RBM 211.13 antibody as fol-
lows. Cells were trypsinized and collected by gently pipeting with a pasteur
pipet and centrifuged. The cells were resuspended in fresh growth medium
at 2-3 x 106 cells/mil and incubated at 37°C for 1 h to allow the cells to
recover from the trypsinization. For sorting, viable cells were used. For
analysis of percentage positive cells, cells were fixed in formaldehyde (see
section on immunofluorescence). After that, cells were centrifuged as above
and resuspended in sterile RBM 211.13 hybridoma supernatant (106
cells/ml) and incubatedat 37°C for30 min. Afterthe incubation, cells were
washed with sterile PBS 3 x by resuspension and centrifugation, incubated
with FITC-conjugated sheep antimouse antibodies as above for 30 min at
37°C and then washed 3x with PBS. Immediately before analysis, cells
were filtered through a 30-mm mesh nylon filter. Samples were run on a
Coulter Epics V cell sorter equipped with an Argon laser operated at 488
nm and 400 mV for fluorescence excitation. Fluorescence was detected with
an S-11 photomultiplier tube at 550 V with a 520-nm barrier filter. For sort-
ing, we set gates to recover the 10% of cells with highest staining and the
10% of cells with lowest staining. Control samples were stained with an
unrelatedhybridoma supernatant or supernatant ofthe SP2/0 myeloma cells
or FITC-(Fabh-SAM alone.
Panning
Preparation ofAntibody-coated Plates. 100-mm Fisher-brand sterile petri
dishes (Fisher) were incubated for 1 h at 37°C with 5 ml of serum-free cul-
ture supernatant ofthe RBM 211.13 hybridoma cells. After incubation, the
antibody solution was recovered, plates were washed 3x with Ca+2-free
PBS to remove residual unbound antibodies, and then incubated with heat-
inactivated (80°C for 3 min) 3% BSA in PBS for 1 h at 37°C. The plates
were then rinsed 3x with 5 nil ofCa+2-free PBS and used immediately for
panning. For controls, we used dishes coated with antibodies in medium
conditioned by other hybridomas or the 3 % BSA solution alone.
Panning. Fig. 8 shows a schema ofthe panning procedures. Primary cul-
tures ofRC cells, grown in supplementedmedium (as above) for 3-4d, were
collected by brief trypsinization, centrifuged, washed, resuspended at 1-2
x 106 cells/nil in W2-free PBS, and then filtered to remove cell clumps
and assure a single cell suspension. 2-4 x 106 cells/dish were incubated
at 37°C on 100-mm Petri dishes previously coated with the RMB 211.13
antibody as above. After 40 min, nonadherent cells were gently removed
by washing with Ca+2-free PBS. Adherent cells were incubated in regular
growth medium for N3 h and then were recovered by trypsinization. Cells
adherent ondishes coated with RBM 211.13 antibodies were compared with
the cells nonadherent to these dishes and the cells nonadherent to BSA-
coated dishes. Nonadherent cells were treated similarly to adherent cells,
in that they were recovered and incubated in tissue culture dishes with
growth medium for the sameperiod oftime as antibody-adherent cells, then
trypsinized. For further analyses, cells recovered after trypsinization were
counted and replated atappropriate densities formeasurement ofAPase ac-
tivity (1-5 x 105 cells/35 mm) or bone nodule formation (105 cell/35-mm
dish).
StatisticalAnalysis
Levels of significance for comparisons between samples were determined
using the two-tailed t test distribution. Results are expressed as the mean
t SD of three to five dishes or samples per point.
375Results
In the fusion in which the RBM 211.13 antibody was iso-
lated, the supernatant from one well showed staining re-
stricted to osteoblasts and the cells close to bone as de-
scribed below. This well was cloned by limiting dilution and
one clone, designated RBM 211.13, was used to prepare all
supernatants and ascites fluid used in these experiments . The
RBM 211.13 antibodies were determined to be of the IgG,
subclass .
Cell and Tissue Staining withRBM211.13
Staining of sections of the top of fetal rat heads, including
the calvaria bone with periosteum, soft connective tissue,
Figure 1. ImmunofluorescencewithRMB 211.13. (A) Hematoxylin-
eosin stain of6Am paraffin section ofthe top ofthe head ofa 21-d
fetal rat . e, epithelium of the skin ; ct, soft connective tissue ; m,
muscle ; b, calvaria bone . The white bracket denotes approximately
the same area as the stained area in B and an equivalent area at
higher power in C ; the bracket encompasses the mineralized bone,
osteocytes, osteoblasts, and preosteoblasts . (B) The antigen recog-
nized by RBM 211.13 was restricted to the osteoblasts along the
bone surfaces, the preosteoblasts in the periosteum for three to
four celllayers behindthe osteoblasts, and thepreosteoblasts on the
endocranial surface of the bone . Most osteocytes and the bone ma-
trixdid not label nor did the fibrous connective tissue . e, epithelium
ofthe skin ; b, bone. (C) Higher magnification of the bone and ad-
jacent osteoblastsand preosteoblasts . B-C are6,um frozensections.
(A, 225x ; B, 225x ; C, 450x) .
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and skin intact showed thatRBM 211 .13 labeled only osteo-
blasts and preosteoblasts in the region three to four cell
layers out from the hone surfaces and most osteocytes were
not labeled (Fig . 1) . Brief treatments of the sections with col-
lagenase, hyaluronidase, trypsin, or pronase did not expose
any cryptic antigenic sites nor obliterate the bone cell-
associated staining (not shown) . In fetal rat long bones, in-
cluding the metatarsal (Fig . 2, A and B) and femur (not
shown), the osteoblasts, the periosteum, chondrocytes of the
hypertrophic zone ofcartilage, and the associated periosteum-
perichondrium were all intensely stained . Resting zone and
proliferating zone chondrocytes were unlabeled . Similar to
sections from the head, soft connective tissue and muscle
were negative (not shown) .
Because the staining pattern and cells expressing the anti-
gen were similar to those that are known to express high
APase activity as detected histochemically, we compared
APase labeling by a histochemical assay (Fig. 2 C) with
RBM 211.13 labeling on the metatarsal and the labeling pat-
terns were nearly identical (see Fig . 2, B and C) . RBM
211.13 did not label fetal kidney but labeled the collecting
tubules of adult kidney and labeled a very few cells in sec-
tions of fetal and adult liver, all similar to the histochemical
APase staining (not shown) . There was no labeling in fetal
intestine, brain, and skin (dermis or epidermis) sections with
RBM 211 .13 antibody (not shown) .
A variety of osteoblastic cells and cell lines were also
tested in vitro . Among the cells of two rat osteoblastic os-
teosarcoma cell lines, virtually all cells were labeled in the
UMR 106.06 population (Fig . 3 A), while a large variation
in intensity of individual cells was obvious in ROS 17/2 .8
(Fig . 3 B) . The pattern was typical of a membrane-
associated molecule with the epitope exposed on the external
surface of live, fixed, or fixed and permeabilized cells . A
gradation of labeling intensity was also obvious in isolated
RC populations in which some cells were not labeled at all
by RBM 211.13, others were labeled slightly, and others were
intensely stained (Fig . 3 C) (see quantitation below) . In
stromal bone marrow populations, which were used for im-
munization in this case, a proportion of cells labeled with a
pattern similar to that seen in fetalRC cells (not shown) . The
proportion of cells labeled in all populations was similar to
the proportion labeling forAPase activity by the histochemi-
cal assay. Fetal rat skin fibroblasts were not labeled with
RBM 211.13. The RBM 211 .13 antibody did not cross-react
with human, mouse, rabbit, and chick osteoblastic cells .
Analysis oftheMolecule Recognized byRBM211.13
Previously, Noda et al . (1988) showed that the APase ofos-
teoblastic cells was attached to the external cell surface via
a glycosyl-phosphatidylinositol (GPI) linkage that is sensi-
tive to phosphatidylinositol-specific phospholipase C (PI-
specific PLC) . When we treated UMR 106.06 cells for 1 h
at 37°C with 20 pg/ml PI-PLC, the labeling with RBM
211.13 was diminished to almost background (not shown) .
Next, we did an immunoprecipitation from 35S-methionine-
labeled macromolecules of UMR 106.06 using the RBM
211.13 antibody. One protein was precipitated with anM
-80 kD under reduced conditions (Fig . 4 A) . On immuno-
blots, on the other hand, RBM 211.13 recognized a band
only when proteins were run under nonreducing conditions
and without boiling samples . Under these conditions, RBM
376Figure 2 . Labeling of frozen sections of metatarsal bones of 21-d fetal rats. (A) Metatarsal bones of the rat stained with hematoxylin-eosin .
Note the development ofthe bony core, the cartilage, and the surrounding fibrous tissue. (B) Immunofluorescence withRBM 211.13. The
osteoblasts of the bony core were labeled, but not the bone matrix . Hypertrophic chondrocytes labeled, but no other chondrocytes or the
cartilage matrix . Theperiosteum labeled intensely, but not the fibrous connective tissue . (C) Localization of alkaline phosphatase (APase)
activity by histochemical stain showed virtually coincident staining of the APase andthe labeling withRBM 211.13 . (A, 175x ; B, 250x ;
C, 150x) .
211.13 recognizedavery broadband with M, -120-150 kD.
This band corresponded to the region containing APase
activity as detected histochemically (Fig . 4 B) . This band
was PNGase F sensitive (Fig . 4 C), suggesting that the
RBM 211.13 antibody recognizes an epitope carbohydrate in
nature .
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RBM211.13positive Cells in Di fferent Fetal
RC Pbpulations
SinceindividualRC cells in culture were stained with differ-
ent intensities from very bright to undetectable with the
RBM 211.13 antibody, we determined by flow cytometry the
377Figure 3. Inununofluorescence with RBM 211.13 on cultured os-
teoblastic cells . RBM 211.13 labeled a surface-associated antigen
present (A) in allUMR 106.06 cells and (B)to varyingdegrees in
individual ROS 17/2 .8 cells . (C)The gradationoflabeling intensi-
ties from cells with intense staining to cells with undetectable label
was also evident in primary cultures of fetal RC cells. (A and B,
480x ; C, 325x).
The Journal of Cell Biology, Volume 114, 1991
Figure 4. SDS-PAGE analysis of UMR cell extracts with RBM
211.13. (A) Immunoprecipitationof"S-methionine-labeled extracts
of UMR 106.06 cells with affinity-purified RBM 211.13 ascites
fluid. 10°% gels run under reducing conditions . (lane 1) Protein
ith knownmolecular masses as indicated. (lane 2) The
ipitatewith M, -80W . (lane3) The unprecipitated
labeled cell extract. (B and C) Immunoblots ofUMRcell extracts
on 10% gels rununder nonreducing, nondenaturing conditions and
proteins transferred to nitrocellulose filters . (B) (lane 1) Detection
of theband of APase activity in UMR cell extracts by staining the
filters with naphthol AS-MX phosphate/Fast Violet . (lane 2 ) Im-
munoblot of the same extracts with RBM 211.13. (C) (lane 1) As
in B, lane 1, but after 24 h incubation ofthe strip in buffer at 37°.
(lane2) Itnmunoblot withRBM211.13 after24 h incubation ofthe
strip with PNGase F
percentage of positive cells in RC populations sequentially
releasedfromfetalcalvariaeby collagenasedigestion . Bycer-
tain criteria, such as response to parathyroid hormone, the
later digesting populations (i.e., RC IIIV) are more osteo-
blastic than are earlier populations (i.e., RCI-II) (Rao et al .,
1977;CohnandWong, 1979 ; Aubin et al ., 1982). Consistent
with this, an increasing number ofRBM 211.13-positive
cells were present in populations RC III, RC IV, and RC V
compared to RC I andRC II . RC 11-V (populationsRC 11-V
mixed to obtain a population large enough for sorting and
immunopanning manipulations) fell between, indicating that
Table L Quantization ofSequentially Released
RCPopulations withRBM211.13
Cells isolated from 21-d fetal RC with collagenase digestion were labeled with
RBM 211.13 and analyzed by flow cytometry . Populations sequentially
released with time ofcollagenase treatment are populations RCI through RCV,
released after 10, 20, 30, 50, and 70 min, respectively . RC iI-V is a population
comprising RC II to RC V mixed together as used in subsequent experiments.
See Materials and Methods for further details .
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Population % Positive
RC 1 3
RC Il 13
RC III 53
RC IV 74
RC V 61
mixed RC 11-V 59the positive cells in the higher population were "diluted" by
negative cells in the lower populations (Table I) .
Cell Sorting withRBM211.13 and Isolation of the
Noduleforming Osteoprogenitor Cell
Previously we have shown that when RC cells are grown in
Figure 5 . Morphological features ofbone nodules formed inRC cell
populations grown in medium supplemented with ascorbic acid and
0-glycerophosphate . (A) By day 10, the RC cells had grownto mul-
tilayered cell sheets. (B) In discrete areas of the culture dish, cells
with a marked polygonal morphology, tight packing and sur-
rounded by refractile matrix were evident by days 12-13 . (C) These
areas became noticeably three-dimensional and became opaque as
they mineralized . (D)A hematoxylin-eosin stain ofa 6-Um paraffin
section of a nodular structure as in C, embedded and cut in cross-
section perpendicular to the floor of the culture dish . The nodule
has all the morphological features of woven bone with a cuboidal
layer of osteoblastic cells on the upper (medium) surface and
osteocyte-like cells embedded in a dense collagenous matrix . For
further details, see Bellows et al ., 1986 and Bhargava et al ., 1988.
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medium supplemented with ascorbic acid andß-glycerophos-
phate, three-dimensional nodular structures formwhich have
the histological, immunohistological (Bellows et al., 1986),
and ultrastructural (Bhargava et al., 1988) appearance of
woven bone (Fig . 5) . In a typical population of RC cells
grown under standard conditions to form bone nodules, the
number of osteoprogenitors is <1%, based on limiting dilu-
tion analysis (Bellows and Aubin, 1989) .We therefore sought
to determine whetherthe bone nodule-forming osteoprogen-
itor cell could be enriched in a population by sorting cells
on the basis ofRBM 211.13 binding . Primary RC cells were
plated for 4-5 d after enzymatic isolation to allow recovery,
then labeled withRBM 211.13, and the fluorescence intensity
profile was determined (Fig. 6) . Windows were set to collect
the 10% of cells with brightest staining and the 10% with
little or no staining . The sorted cells were then assessed for
their ability to formbone nodules under standard conditions.
No nodule-forming osteoprogenitors were recovered in the
sorted cells negative forRBM 211.13 labeling . Bone nodule-
forming cells were present in the cells sorted for intense
RBM 211.13 staining (Fig . 7 A) . However, a series of control
experiments with labeled and unlabeled cells indicated that
not all the nodule-forming cells expected on a per plated cell
basis were being recovered, suggesting that mechanical trau-
ma caused by the shear forces in the flow stream caused at
leastsome of the nodule-forming osteoprogenitor cells to be
lost (Fig . 7) .
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Figure 6 Flow cytometry with primary RC cells . Mixed popula-
tions RC H-V were cultured for 5-6 d before labeling with RBM
211.13. (X axis) Log fluorescence intensity, arbitrary scale channels
1-256. (Y axis) Relative cell frequency. The gate for collection of
the 10% of cells with lowest intensity labeling is indicated in the
top panel and that for the 10% with most intense labeling is shown
in the bottom panel .m
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Figure 7. Bone nodule formation by cells sorted for low or high
staining with RBM 211.13. RC cells sorted as described in Fig. 6
were collected, plated at 105 cells/35-min tissue culture dish, and
grown for bone nodule formation as described in Materials and
Methods. (A) In the absence of DEX; (B) in the presence of DEX.
Cells labeled with antibody and passed through the flow stream
without sorting (PASS) had fewer nodules than the same cells with-
out passing through the flow stream (CO) in the absence (A) or in
the presence (B) of DEX. Significantly different from the corre-
sponding control, *, P < 0.05, ***, P < 0.001. Cells sorted on the
basis of intense staining with RBM 211.13 (HIGH) formed many
bone nodules, while those sorted forlow staining (LOW) made very
few nodules. Significantly different from PASS or HIGH, ***, P <
0.001. DEX stimulated nodule formation in all populations; the fold
stimulation in DEX treated versus untreated populations in CO was
10 f 0.3, in PASS was 9 f 0.2, in the HIGH population 7 f .3,
and in the LOW population 11 f 1. Bars represent the means f
SD of five dishes.
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Because of the apparent sensitivity of nodule-forming osteo-
progenitor cells to passage through the flow stream of the
cell sorter, we used immunopanning on RBM 211.13-coated
petri dishes for further experiments (Fig. 8). Over a 30-45-
min period, 40-60 % of the RC population became attached
to petri dishes coated with RBM 211.13. Over the same pe-
riod, virtually no RC cells attached to dishes coated with
BSA. As expected, APase activity was enriched in cells
panned by adherence to RBM 211 .13 and depleted in the pop-
ulation not adherent to RBM 211.13 (Fig. 9) .
We next sought to determine whether the bone nodule-
forming osteoprogenitors could be enriched in the adherent
or the nonadherent fraction, i.e., if they were present in the
APase-positive or APase-negative pools. A time course of
adherence to RBM 211.13 indicated that among the pool at-
taching in the first 15 min were few bone nodule-forming
cells; concomitantly they were found in the nonadherent
population. By 30-45 min, however, the majority ofthe bone
nodule-forming cells was found in the adherent pool (Fig.
10). Therefore, an adhesion time of 45 min was used in all
subsequent experiments. Taking the BSA-nonadherent frac-
tion as representative of the mixed RC population, valid
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Figure 8. Schema of the immunopanning procedure. Petri dishes
were prepared by pretreatment with BSA or the antibody RBM
211.13. Primary populations RC H-V were collected and divided
into equal aliquots. One aliquot was incubated on the BSA-coated
plates; virtually no cells attached yielding the BSA nonadherent
control (BSA NA) population. One aliquot was added to the RBM
211.13-coated dishes, yielding an RBM 211.13 adherent population
and an RBM 211.13 nonadherent population. All populations were
recoveredand replated at equivalent cell numbers for determination
of alkaline phosphatase (APase) activity or for bone nodule for-
mation.
BSA NA
￿
211 A
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Figure 9. Determination of alkaline phosphatase (APase) activity
in the control (unfractionated, BSA NA) population compared to
the RBM 211.13 adherent (211 A )and the RBM 211.13 nonadherent
(211 NA) population. Cells panned as in Fig. 8 were collected and
plated at equivalent cell numbers in 35-mm dishes. 48 h later,
APase was determined as in Materials and Methods. APase activity
was enriched in the 211 adherent population and depleted in the
nonadherent population compared to control population. Bars rep-
resent the means t SD of triplicate dishes. Significantly different
from BSA NA, ** P < 0.03, ***, P < 0.001.m
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Figure 10. Time course of adhesion of bone nodule-forming os-
teoprogenitor cells to RBM 211.13-coated petridishes. Cells were
panned as in Fig. 8 and the211 adherent (211 A) andthe211 nonad-
herent (211 NA) populations were collected at various times and
replated undertheconditions ofbone nodule formation. At 15 min,
most nodule-forming cells were stillin thenonadherent population .
By 30-45 min, most nodule-forming cells were in the adherent
fraction. Bars represent the means t SD of five dishes. Signifi-
cantly different from 211A15', ***, P < 0.001.
given that no cells attached to the BSA, we found an ap-
proximately two- to threefold enrichment for bone-forming
osteoprogenitor cells in the RBM 211.13-adherent cells and
a concomitant depletion in the RBM 211.13 nonadherent
pool (Fig. 11).
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Figure 11. Enrichment of the bone nodule-forming cells after im-
munopanning. Primary RC cellswere panned for 45 minas in Fig.
8, collectedand plated at equivalent cell numbers forbone nodule
formation. 211 adherent (211 A) and 211 nonadherent (211 NA)
populations were compared with the unfractionated control, BSA
nonadherent (BSA NA)population. Thenumber of nodules formed
on aper plated cell basis was greater in the 211 A and less in the
211 NA population compared to control (BSA NA). Significantly
different from BSA NA, ***, P < 0.001.
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Figure 12. Enrichment of thebone nodule-forming cells after im-
munopanning. PrimaryRC cells were panned for45 minas in Fig.
8, collected and plated at equivalent cell numbers forbone nodule
formation in the absence (A) or the presence (B) of DEX. 211 ad-
herent (211 A) and 211 nonadherent ( NA) populations were com-
paredwith theunfractionated control, BSA nonadherent (BSA NA)
population. Thenumber of nodutes formed on aperplated cell ba-
sis was greater in the211 A and less in the211 NA population com-
pared to control (MA-WA). DEX.stimulated nodule formation in
allpopulations, howeverthefold stimulation in DEX treatedversus
untreated cells in BSA NA was 8 f 0.3, in 211 A was 5 ±0.4 and
in 211 NA was 33 f 0.8, Bars representthe means t. SD of five
dishes. Significantly different from BSA NA, ***, P < 0.001.
Earlier, we reported that glucocorticoids such as DEX
stimulatebone nodule formationin RC populations by induc-
ing expression of bone formâtion by cells that do not form
bone in theabsenceof DEX (Bellows et al., 1987, 1990). We
therefore determined whether the cells requiring DEX for
bone formation were restricted to either of the extreme ends
of thepopulations sorted by flow cytometry and/or theRBM
211.13-adherent or the nonadherentfraction of cells or were
present in both. DEX caused a large increase in expression
of nodule formation in the APase-negative sorted cells and
a somewhat smaller response in the APase-positive sorted
cells (Fig. 7 B) . Similarly, in a typicalpanning experiment,
bone nodule-forming cellswere enriched in the'211-adherent
fraction and depleted from the 211-nonadherent fraction
(Fig. 12 A). DEX elicited an approximately eightfold in-
crease in the number of nodules in the control,(unpanned;
BSA-nonadherent) population. In the RBM 211.13-adherent
population, DEX elicited a 5-fold increase, and in th&RBM
211.13-nonadherent population, a 33-fold increase in the
number ofbone nodulesformed compared to the same popu-
lations in the absence of DEX'(Fig. 12 B) :
￿
`
In this paper, we have describedthe isolationof amAbreact-
ing selectively with osteoblastic cells in vivo and in vitro.
Characterization of the antibody showed that it recognizes
thebone-liver-kidney isoenzymeofratAPase.-This evidence
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CD r Nincludes the localization of the staining coincident with the
histochemical staining for APase, the release of the antigen
by PI-PLC, immunoprecipitation, and immunoblotting. Our
data further indicate that RBM 211.13 recognizes an epitope
present in the nonreduced form of the native molecule and
possibly carbohydrate in nature. Since the antibody recog-
nizes an epitope present on the external face of the plasma
membrane of living cells, we have used it to separate APase-
positive and APase-negative cells, and have determined that
the nodule-forming osteoprogenitor cell present at low fre-
quency (<1%) in typical RC mixed populations can be recov-
ered from the heterogeneous population in the fraction of
cellsexpressing APase. On the other hand,the osteoprogeni-
tor cells requiring glucocorticoids to form bone were en-
riched in the APase-negative fraction . We have, therefore,
described a combined approach in which expression of sur-
face molecules detected immunologically can be used to
study the osteoblast lineage by isolation or enrichment for
cells that functionally can make bone in culture.
Data from several labs have confirmed that the populations
ofcellsisolated from fetalratcalvariae are heterogeneous for
theexpression ofosteoblastic properties (Wong, 1980; Aubin
et al ., 1982; Heersche and Aubin, 1990). Although several
procedureshave been used to enrich for or purify subpopula-
tions, no technique has yetbeen reported in which a subpopu-
lation has been isolated specifically on the basis ofexpression
of a particular osteoblast marker. Using the mAb RBM
211.13, we have enriched for the cells expressing high APase
activity in RC populations and also obtained a pool in which
APase activity is low. In vivo, APase-positivecellsare hetero-
geneous and include the postmitotic functional osteoblast on
the bone surface and the proliferative cells comprising the
three to four cell layers residing behind the osteoblasts,
which are thought to be preosteoblasts and osteoprogenitor
cells at different stages ofdifferentiation. The level ofAPase
has been used routinely in in vitro experiments as a marker
of osteoblast differentiation. It is generally accepted that as
the specific activity of APase in a population changes there
is a corresponding change in the state of differentiation of
cells, i.e., increases in APase activity reflect a maturation
from an earlier to a more mature stage ofosteoblast differen-
tiation (Rodan and Rodan, 1984). Clearly, some cells in our
APase-positive pool did proliferate and we could visualize
mitotic, APase-positive cells, probably representative of the
preosteoblast pool rather than mature osteoblasts. Over a
time of 2-3 d after panning, the cells with "high» or "low"
APase continued to express relatively high or low activities,
respectively. In preliminary experiments, we have found that
with longer time (>5 d), however, APase activity decreased
in the initially high APase population, perhaps reflectingter-
minal differentiation to APase-negative cells that would be
consistent with maturation of APase-positive cells to osteo-
cyte-like cells and increased in DEX in the initially low
APase population, perhaps reflecting their maturation to
more differentiated cells (data not shown).
The time course for adherence of RC cellsto RBM 211.13-
coated dishes showed that maximum attachmentof cellsoc-
curred after 30-45 min at 37°C. It was ofparticular note that
the cells capable of forming bone nodules in the absence of
DEX were specifically enriched in the APase-positive (211-
adherent) population and depleted from the APase-negative
(211-nonadherent) population with time. This is consistent
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with the cells sorted by flow cytometry in which, without
DEX, nodule-forming cells were found in the fraction of
cells sorted for high intensity staining with the APase anti-
body and were not present in the fraction with low intensity
staining. Thus, it appeared that the bone nodule-forming os-
teoprogenitor could be recovered in the APase-positive
fraction, suggesting that the cellsforming bone in the absence
of glucocorticoids are relatively late in the differentiation
pathway from committed cell to osteoblasts. Consistent with
this, earlier we found that the bone nodule-forming cell also
has a relatively small proliferative capacity, i .e., is present
in populations only up to a populationdoubling level of -10
(Bellows and Aubin, 1989; Bellows et al., 1990). One must
keep in mind, however, that under standard conditions,
ti 0.3 % ofthecellsin amixedRC population arebonenodule-
forming osteoprogenitors while40-60 % are APase-positive.
Thus, the osteoprogenitors sorted on the basis of APase ac-
tivity are a small subpopulation of the total APase-positive
pool. We have argued elsewhere that the osteoprogenitor
must go through approximately five to six doublings to form
a visible nodule (Bellows and Aubin, 1990), suggesting that
these cells are a subpopulation of APase-positive cells still
with some capacity, albeit limited, to divide.
Earlier, we found that DEX stimulated the proliferation of
bone nodule-forming osteoprogenitor cells, resulting in the
average size of a nodule being bigger in cultures grown in
DEX than in cultures without DEX (Bellows et al., 1990).
In addition, a second class of bone nodule-forming os-
teoprogenitor was present in RC populations, which made
bone in culture only if DEX was present in the culture
medium (Bellows et al., 1987, 1990). The additional nodules
formed in the presence of DEX could have resulted from
DEX increasing the proliferative capacity of more mature
osteoprogenitor cells so that they achieved a sufficientnum-
ber of cell divisions to form a visible nodule. However, an-
other possibility was that DEX was acting upon a population
of osteoprogenitors that required glucorticoids to proliferate
and/or differentiate along the osteogenic pathway. The sec-
ond major conclusion to be drawn from our current experi-
ments is that the DEX-requiring osteoprogenitor may be a
less mature cell, not yet expressing APase on its surface (and
therefore present in the APase-negative or nonadherent
population), and that this cell type either will not proliferate
and/or differentiate into bone nodule-forming cells inthe ab-
sence of DEX. Consistent with their being relatively imma-
ture was the finding that in the presence ofDEX nodules con-
tinued to form "later" in theculture period than in its absence
(Bellows et al., 1987). The smaller fold increase in nodule
number in the APase-positive population may result from
DEX acting to increase the proliferative capacity of the more
mature, APase-positive cellsso that a detectable nodule may
form as we had suggested earlier. However, an equally likely
possibility is "contamination" of the adherent cells by the
DEX-requiring cells in the nonadherent, APase-negative
fraction, because it is difficult technically to remove all
nonadherent cells from the adherent population.
Even though it is clear thatpanning is well adapted to large
scale preparations, it does suffer from the limitation that a
lack ofpurity is achieved in many instances, especially when
the desired population is present in low frequency. Neverthe-
less, it is clear that we did achieve enrichment for popula-
tions of cells present at <1% of the whole cell population.
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Figure 13 Aproposedlineage diagram with differentiation steps forcellsof the osteoblast lineage. Immunoselection with antibodies against
APase allowed discrimination of an APase-positive osteoprogenitor (OP) making bone in vitro without DEX (late OP) from an earlier
APase-negative OP (early OP), which in vitro proliferates and/or differentiates only in the presence of DEX. We have superimposed on
this scheme where we think these types of OP cells reside in comparison to cells expressing other osteoblast markers, For conciseness
andease of comparison, this table is based primarily on immunocytochemical evidence for the expression ofosteoblast-associated markers.
However, other biochemical approaches support the data referenced (for reviews see RodanandRodan, 1984; Nijweide et al., 1986; Martin
et al., 1987; Butler, 1989). 1, Doty and Schofield, 1976. 2, Mark et al., 1987a. 3, Turksen and Aubin, current paper. 4, Bronckers et
al., 1985. S, Mark et al., 1987b. 6, Chen et al., 1991. 7, Rouleau et al., 1988, 1990. 8, Rodan and Rodan, 1984; Martin et al., 1987.
9, Tenenbaum and Heersche, 1985. 10, Bellows et al., 1987; Bellows and Aubin, 1989.
As importantly, we have shown that expression of APase ac-
tivity can be used to separate osteoprogenitors that do not
require glucocorticoids (positive selection) from those that
require glucocorticoids (negative selection) to make bone.
Ourdata areconsistentwith theformer being amore mature,
less proliferative population and the latter a less mature,
more proliferative population. On the basis of the im-
munoselection and functional assay for bone formation de-
scribed here, we propose alineage scheme in which we now
identify a less mature, APase-negative, glucocorticoid-
requiring osteoprogenitor separate from a later APase-
positive osteoprogenitor, and we have tentatively placed
these cells along a lineage path encompassing cells express-
ing other osteoblastic markers (Fig. 13).
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